I think the big story now is AztraZenica. Keep an eye on a private company--
Vaccitech Ltd." >About Vaccitech Ltd.
I've started to dig into the murky world of who is going to get paid for these vaccines. There is a web of people from Oxford, through Bill Gates and ultimately some of these threads tie back to a unknown and for now private Biotech. There is some serious smoke here folks...
Vaccitech currently has a Phase 2a clinical programme for prostate cancer and is poised to enter the clinic with HPV and NSCLC therapeutics. The company is backed by leading institutions including Google Ventures, Sequoia China and Oxford Science Innovation.
Backed by Google?
The company's proprietary technology platform, comprising Chimpanzee Adenovirus (prime) and MVA (boost) is exceptional at inducing, boosting and maintaining CD8+ and CD4+ T cells. The Vaccitech prime-boost platform is licenced from one of the most prestigious vaccine research institutes in the world, the Jenner Institute at University of Oxford.
Ok Remember that name ' The Jenner Institute..'
Vaccitech currently has a Phase 2a clinical programme for prostate cancer and is poised to enter the clinic with HPV and NSCLC therapeutics. The company is backed by leading institutions including Google Ventures, Sequoia China and Oxford Science Innovation.
Backed by Sequoia China?
“I personally don’t believe that in a time of pandemic there should be exclusive licenses,” Adrian Hill, director of Oxford’s Jenner Institute, which is developing the vaccine,told The New York Times in April.
No vaccine maker has offered open licenses, although NIH is sharing key technology it developed with multiple vaccine companies. Governments are signing lucrative deals with manufacturers to ensure vaccines for their own populations.
After Oxford announced the exclusive AstraZeneca deal, the company said it would sell vaccines at no profit—but only during the pandemic. Johnson & Johnson’s pledge to earn no vaccine profit is similarly limited.
No Profit during pandemic.... But what if this is a rolling flue shot situation? I think the big surprise is going to be how short the protection lasts because that's the one test they cannot do in a sped up approval process. Length of protection will be a surprise to all of us one way or another.
Enter Vaccitech)
Under its deal with AstraZeneca, Oxford will receive no royalties during the pandemic but could make millions after it ends through a web of patents including those held by Vaccitech, a for-profit spinoff. Vaccitech’s ownership includes a 50% stake held directly or indirectly by Oxford and 5.25% each owned by Hill and Jenner’s other top vaccine scientist, Sarah Gilbert, U.K. regulatory filings show.<<- that name ' The Jenner Institute..'
Enter Bill Gates)
Oxford backed off from its open-license pledge after the Gates Foundation urged it to find a big-company partner to get its vaccine to market.<----
“We went to Oxford and said, Hey, you’re doing brilliant work,” Bill Gates told reporters on June 3, a transcript shows. “But … you really need to team up.” The comments were first reported by Bloomberg.<---
AstraZeneca, one of the U.K.’s two major pharma companies, may have demanded an exclusive license in return for doing a deal, said Ken Shadlen, a professor at the London School of Economics and an authority on pharma patents—a theory supported by comments from CEO Soriot.<---- BIG
“I think IP [intellectual property, or exclusive patents] is a fundamental part of our industry and if you don’t protect IP, then essentially there is no incentive for anybody to innovate,” Soriot told the newspaper The Telegraph in May.
Some see the Gates Foundation, a heavy funder of Gavi, CEPI and many other vaccine projects, as supporting traditional patent rights for pharma companies.
>>> So the Gates foundation has ' suggested ' it would be better to partner up with AZN and to make a little profit....
Well take all of this and add to it a President who is want to accelerate the approval process to just before his landslide loss...
And we have to ask ourselves just where will AztraZenica wind up? Keep in mind if they make too much money they will have to hide it...
And if we all see an IPO for Vaccitech, well we know why, that's a prime place to hold some of these profits so it doesn't look like AZN & Oxford are gouging the world.
The dollar amounts here of course are staggering...
Vaccitech Ltd." >About Vaccitech Ltd.
I've started to dig into the murky world of who is going to get paid for these vaccines. There is a web of people from Oxford, through Bill Gates and ultimately some of these threads tie back to a unknown and for now private Biotech. There is some serious smoke here folks...
Vaccitech currently has a Phase 2a clinical programme for prostate cancer and is poised to enter the clinic with HPV and NSCLC therapeutics. The company is backed by leading institutions including Google Ventures, Sequoia China and Oxford Science Innovation.
Backed by Google?
The company's proprietary technology platform, comprising Chimpanzee Adenovirus (prime) and MVA (boost) is exceptional at inducing, boosting and maintaining CD8+ and CD4+ T cells. The Vaccitech prime-boost platform is licenced from one of the most prestigious vaccine research institutes in the world, the Jenner Institute at University of Oxford.
Ok Remember that name ' The Jenner Institute..'
Vaccitech currently has a Phase 2a clinical programme for prostate cancer and is poised to enter the clinic with HPV and NSCLC therapeutics. The company is backed by leading institutions including Google Ventures, Sequoia China and Oxford Science Innovation.
Backed by Sequoia China?
“I personally don’t believe that in a time of pandemic there should be exclusive licenses,” Adrian Hill, director of Oxford’s Jenner Institute, which is developing the vaccine,told The New York Times in April.
No vaccine maker has offered open licenses, although NIH is sharing key technology it developed with multiple vaccine companies. Governments are signing lucrative deals with manufacturers to ensure vaccines for their own populations.
After Oxford announced the exclusive AstraZeneca deal, the company said it would sell vaccines at no profit—but only during the pandemic. Johnson & Johnson’s pledge to earn no vaccine profit is similarly limited.
No Profit during pandemic.... But what if this is a rolling flue shot situation? I think the big surprise is going to be how short the protection lasts because that's the one test they cannot do in a sped up approval process. Length of protection will be a surprise to all of us one way or another.
Enter Vaccitech)
Under its deal with AstraZeneca, Oxford will receive no royalties during the pandemic but could make millions after it ends through a web of patents including those held by Vaccitech, a for-profit spinoff. Vaccitech’s ownership includes a 50% stake held directly or indirectly by Oxford and 5.25% each owned by Hill and Jenner’s other top vaccine scientist, Sarah Gilbert, U.K. regulatory filings show.<<- that name ' The Jenner Institute..'
Enter Bill Gates)
Oxford backed off from its open-license pledge after the Gates Foundation urged it to find a big-company partner to get its vaccine to market.<----
“We went to Oxford and said, Hey, you’re doing brilliant work,” Bill Gates told reporters on June 3, a transcript shows. “But … you really need to team up.” The comments were first reported by Bloomberg.<---
AstraZeneca, one of the U.K.’s two major pharma companies, may have demanded an exclusive license in return for doing a deal, said Ken Shadlen, a professor at the London School of Economics and an authority on pharma patents—a theory supported by comments from CEO Soriot.<---- BIG
“I think IP [intellectual property, or exclusive patents] is a fundamental part of our industry and if you don’t protect IP, then essentially there is no incentive for anybody to innovate,” Soriot told the newspaper The Telegraph in May.
Some see the Gates Foundation, a heavy funder of Gavi, CEPI and many other vaccine projects, as supporting traditional patent rights for pharma companies.
>>> So the Gates foundation has ' suggested ' it would be better to partner up with AZN and to make a little profit....
Well take all of this and add to it a President who is want to accelerate the approval process to just before his landslide loss...
And we have to ask ourselves just where will AztraZenica wind up? Keep in mind if they make too much money they will have to hide it...
And if we all see an IPO for Vaccitech, well we know why, that's a prime place to hold some of these profits so it doesn't look like AZN & Oxford are gouging the world.
The dollar amounts here of course are staggering...
Last edited: